Autor: |
Jincong Q. Freeman, Sarah Shubeck, Frederick M. Howard, Nan Chen, Rita Nanda, Dezheng Huo |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
npj Breast Cancer, Vol 9, Iss 1, Pp 1-4 (2023) |
Druh dokumentu: |
article |
ISSN: |
2374-4677 |
DOI: |
10.1038/s41523-023-00536-z |
Popis: |
Abstract OncotypeDX and MammaPrint assays have not been validated to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) in early-stage breast cancer patients. We analyzed the 2010–2019 National Cancer Database and found that high OncotypeDX recurrence scores or high MammaPrint scores were associated with greater odds of pCR. Our findings suggest that OncotypeDX and MammaPrint testing predict pCR after NACT and could facilitate clinical decision-making between clinicians and patients. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|